BSX – Boston Scientific Corporation – Fundamental analysis, financial statements, key ratios, and fair value analysis

Boston Scientific Corporation

Healthcare
Medical Devices
34.21
1.3
3.95%
39.04
25.2
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)0.48
EPS Estimate Currrent Qtr0.37
Book Value Per Share5.99
Market Cap 47 Billion
PE Ratio 70.2
Dividend YieldNA

Stock Yield

Stock Return 7 Days9.27%
Stock Return 15 Days1.82%
Stock Return 30 Days -9.97%
Stock Return 3 Months-11.19%
Stock Return One Year37.14%
Stock Return 3 Years39.79%

Stock Technical Analysis

Relative Strengh Index (14)32.44
Average True Range (14)1.34
Momentum (14)-4.19
Simple Moving Average (14) -4.19
Time Series Forecast (14)33.03
Time Series Forecast (30) 37.14

Stock News

Financial Statements

index2014201520162017
Revenue7 Billion7 Billion8 Billion9 Billion
Cost of Revenue2 Billion2 Billion2 Billion3 Billion
Gross Profit5 Billion5 Billion6 Billion6 Billion
Gross Margin (%)70.05%70.94%71.09%71.34%
Selling General and Administrative Expense3 Billion3 Billion3 Billion3 Billion
Other operating expenses3 Billion3 Billion2 Billion2 Billion
Earning Before Interest and Taxes EBIT-293 Million-366 Million410 Million1 Billion
EBIT/Operating Margin (%)-0.00%-0.00%4.89%12.83%
Interest Expense216 Million284 Million233 Million229 Million
Other non-operating expenses/income0000
Earnings before Tax-509 Million-650 Million177 Million932 Million
Income Tax Expense-390 Million-411 Million-170 Million828 Million
Net Income-119 Million-239 Million347 Million104 Million
Net Margin (%)-0.00%-0.00%4.14%1.15%
Earnings per share from operating income-27-94.72622139.543
Earnings per Diluted Share-0-00.250.08
Dividends per Basic Common Share0000
Weighted average number of shares outstanding1 Billion1 Billion1 Billion1 Billion
index2017 Q42018 Q12018 Q22018 Q3
Revenue2 Billion2 Billion2 Billion2 Billion
Cost of Revenue674 Million672 Million739 Million672 Million
Gross Profit2 Billion2 Billion2 Billion2 Billion
Gross Margin (%)72.01%71.75%70.32%71.92%
Selling General and Administrative Expense886 Million860 Million886 Million870 Million
Other operating expenses565 Million462 Million462 Million337 Million
Earning Before Interest and Taxes EBIT283 Million385 Million403 Million514 Million
EBIT/Operating Margin (%)11.75%16.18%16.18%21.48%
Interest Expense57 Million61 Million57 Million58 Million
Other non-operating expenses/income0000
Earnings before Tax226 Million324 Million346 Million456 Million
Income Tax Expense841 Million26 Million-209 Million24 Million
Net Income-615 Million298 Million555 Million432 Million
Net Margin (%)-0.00%12.53%22.29%18.05%
Earnings per share from operating income1.045826.152131.815323.83811
Earnings per Diluted Share-00.210.40.31
Dividends per Basic Common Share0000
Weighted average number of shares outstanding1 Billion1 Billion1 Billion1 Billion
index2014201520162017
Cash and Equivalents587 Million319 Million196 Million188 Million
Trade and Non Trade Receivables1 Billion1 Billion1 Billion2 Billion
Inventory946 Million1 Billion955 Million1 Billion
Other current assets2 Billion1 Billion1 Billion1 Billion
Current Assets4 Billion3 Billion3 Billion4 Billion
Total Non-Current Assets13 Billion15 Billion15 Billion15 Billion
Total Assets17 Billion18 Billion18 Billion19 Billion
Trade and Non Trade Payables262 Million209 Million447 Million530 Million
Other current liabilities3 Billion2 Billion3 Billion5 Billion
Current Liabilities3 Billion2 Billion4 Billion6 Billion
Liabilities Non Current8 Billion9 Billion8 Billion6 Billion
Accumulated Retained Earnings Deficit-9 Billion-9 Billion-9 Billion-8 Billion
Shareholder’s equity other15 Billion15 Billion15 Billion15 Billion
Shareholders Equity6 Billion6 Billion7 Billion7 Billion
Noncontrolling interests6 Billion5 Billion7 Billion11 Billion
Total Assets17 Billion18 Billion18 Billion19 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents188 Million287 Million208 Million168 Million
Trade and Non Trade Receivables2 Billion2 Billion2 Billion2 Billion
Inventory1 Billion1 Billion1 Billion1 Billion
Other current assets1 Billion2 Billion1 Billion1 Billion
Current Assets4 Billion4 Billion4 Billion4 Billion
Total Non-Current Assets15 Billion15 Billion16 Billion16 Billion
Total Assets19 Billion19 Billion20 Billion20 Billion
Trade and Non Trade Payables530 Million404 Million403 Million453 Million
Other current liabilities5 Billion5 Billion4 Billion5 Billion
Current Liabilities6 Billion5 Billion5 Billion5 Billion
Liabilities Non Current6 Billion7 Billion7 Billion7 Billion
Accumulated Retained Earnings Deficit-8 Billion-8 Billion-8 Billion-7 Billion
Shareholder’s equity other15 Billion15 Billion16 Billion16 Billion
Shareholders Equity7 Billion7 Billion8 Billion8 Billion
Noncontrolling interests11 Billion10 Billion10 Billion10 Billion
Total Assets19 Billion19 Billion20 Billion20 Billion
index2014201520162017
Net Cash Flow from Operations1 Billion691 Million1 Billion1 Billion
Capital Expenditure-259 Million-247 Million-347 Million-319 Million
Net Cash Flow from Investing-745 Million-2 Billion-887 Million-1 Billion
Net Cash Flow from Financing-150 Million1 Billion-206 Million110 Million
Cash and Equivalents587 Million319 Million196 Million188 Million
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations872 Million193 Million-403 Million501 Million
Capital Expenditure-79 Million-60 Million-74 Million-76 Million
Net Cash Flow from Investing-289 Million-173 Million-491 Million-662 Million
Net Cash Flow from Financing-68 Million130 Million726 Million151 Million
Cash and Equivalents188 Million287 Million208 Million168 Million

Stock Price History

table